Sravanthi Parasa, MD, gastroenterologist at Swedish Gastroenterology, talks about innovations in gastroenterology technology.
While there aren't many widely-used digital therapeutics in gastroenterology yet, there are many other tehnologies like virtual reality that are growing more and more popular in the field, said Sravanthi Parasa, MD, gastroenterologist at Swedish Gastroenterology.
Transcript
How are digital therapeutics being used in gastroenterology?
I think gastroenterology is not as much exposed to digital therapeutics yet, but there are several upcoming companies that are using various modes. We now know that virtual reality can help with pain, irritable bowel syndrome [IBS], those kinds of things. So, those technologies will probably come up for commercial use in the near future. That's in terms of VR [virtual reality] kind of things.
From a measurement standpoint, right now we have some innovation happening in the IBD [inflammatory bowel disease] space, mostly. Because, if a patient has increased bowels, or we don't know if they're going into a flare, or it's their underlying IBS that's getting worse, you can actually have a kit for fecal calprotectin, which is a measure that we look at when we're looking at inflammation. That kit, you can do it at home. The patient doesn't need to come into the hospital. And you can use your smartphone to know the calprotectin level and that can communicate to your physician's office. You can say, "hey, the [calprotectin level] is high, so I think you are ill. So you need to come into the hospital," or something like that. So there are some technologies out there, but not really directly like a wearable, like Apple Watch, unless you're looking at the role of exercise or some other things for a disease outcome.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More